Vanberra Signal
Free trial

OptoTree

Curated by Signal

Provider of an ophthalmic image diagnosis platform for healthcare professionals

Health Technologyoptotree.com

Overview

Provider of an ophthalmic image diagnosis platform for healthcare professionals. The company has developed a software called Vasculomics that assist in analyzing retinal images for early diagnosis of any disease. It is an automated tool that provides quantitative reports for the assessment of retinal images. The technology used in the software has the ability to detect tumors and signs of angiogenesis in order to treat the patient. The system uses analytical vascular metrics technology to diagnose tumor angiogenesis in the retina of a patient

Key facts

Founded
2010
Headquarters
Framingham, United States
Stage
Sign up to view
Industry
Health Technology

Business model

3 products and services
Sign up to view
Commercial model
Sign up to view

Contact

Email
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • BioNews

    BioNews – WE ARE RARE

    Health TechnologyPensacola, United States

  • Bay Labs

    Developer of deep learning-based medical imaging diagnostics for heart diseases

    Health TechnologySan Francisco, United States

  • Colonai

    AI-based disease diagnosis tool for gastroenterologists

    Health TechnologyNew York City, United States

About OptoTree

What does OptoTree do?

Provider of an ophthalmic image diagnosis platform for healthcare professionals.

Where is OptoTree headquartered?

OptoTree is headquartered in Framingham, United States.

When was OptoTree founded?

OptoTree was founded in 2010.

Which sector is OptoTree in?

OptoTree operates in Health Technology.

Who are OptoTree's competitors?

Companies similar to OptoTree include BioNews, Bay Labs, and Colonai.